Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer.
Holdenrieder
Stefan
S
Institute of Clinical Chemistry, University of Munich, Munich, Germany. Stefan.Holdenrieder@med.uni-muenchen.de
Stieber
Petra
P
von Pawel
Joachim
J
Raith
Hannelore
H
Nagel
Dorothea
D
Feldmann
Knut
K
Seidel
Dietrich
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002272:Carcinoembryonic Antigen / Q000096:biosynthesis; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D053539:Keratin-19; D007633:Keratins / Q000378:metabolism; D007700:Kinetics; D008175:Lung Neoplasms / Q000097:blood* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009707:Nucleosomes / Q000378:metabolism*; D013997:Time Factors; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; D009707:Nucleosomes; C102012:antigen CYFRA21.1; D007633:Keratins